Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study

Abstract

The consistent observations of this and other studies are provocative and worthy of evaluation with a prospective randomized trial using objective measures of migraine frequency and severity. However, it seems too early to recommend PFO closure for all patients who suffer from migraine until the results of ongoing large randomized trials are available.